Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy
Advanced Science · 2026-11 · 13 (61)
DOI: 10.1002/advs.77020 ↗At a glance
Journal article in Advanced Science, published online on 2026-08-11. Written by Hongxiang Zeng and 16 co-authors. Institution: Faculty of Synthetic Biology, and Institute of Cell and Gene Technology, Shenzhen University of Advanced Technology, Shenzhen, China. Major MEDLINE topics: Plant Growth Regulators, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, T-Lymphocytes. 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China, Shenzhen-Hong Kong joint Science and Technology Innovation Program, National Natural Science Foundation of China.
Abstract (original language)
Precise regulation of chimeric antigen receptor (CAR)‐T cell activity is essential to maximize efficacy and minimize toxicity. While switch‐controlled CAR‐T holds great promise, challenges remain in achieving accurate activation, reducing immunogenicity, and preventing off‐target effects. Here we present a novel inducible ON‐switch CAR design that leverages plant hormone signaling components to achieve controllable T cell activation. By engineering a receptor system integrating the plant auxin receptor AFB1 with its co‐receptor IAA7, we enable ligand‐dependent interactions triggered by the plant hormone auxins. This design allows rapid, reversible, and dose‐dependent T cell activation, resulting in potent cytotoxicity against B‐cell lymphoma in vitro and in vivo. Notably, auxCAR‐T cells controlled by synthetic auxin analogs maintain a favorable memory phenotype and exhibit reduced functional exhaustion during treatment, leading to improved therapeutic efficacy. Our plant hormone‐based orthogonal system overcomes key limitations of existing switch systems and advances the development of precision CAR‐T therapies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Faculty of Synthetic Biology, and Institute of Cell and Gene Technology, Shenzhen University of Advanced Technology, Shenzhen, China.
- State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
- Department of Chemistry, New York University, New York, USA.
- New York University-East China Normal University Center for Computational Chemistry, School of Chemistry and Molecular Engineering, New York University Shanghai, Shanghai, China.
- The First Affiliated Hospital of Xiamen University, School of Medicine, Clinical Research Institute, Xiamen University, Xiamen, China.
- Institute of Emerging Agricultural Technology, Shenzhen University of Advanced Technology, Shenzhen, China.
ORCID profiles: Hongxiang Zeng, Lei Zheng, Rongkun Tao, Peng Zhang, Xiang Zhou, Zhaoxi Sun, Qizhou Lian
Funding
- National Key Research and Development Program of China
- Shenzhen-Hong Kong joint Science and Technology Innovation Program
- National Natural Science Foundation of China
- National Natural Science Foundation of China Grant
- Shenzhen Science and Technology Program
- Shenzhen Science and Technology Innovation Program
Cite
APA
Zeng, H., Zheng, L., Tao, R., Zheng, S., Zhong, Y., Niu, Y., Zhang, P., Ma, X., Yang, C., Zhang, M., Duan, F., Yang, J., Wei, X., Zhou, X., Yang, Z., Sun, Z., & Lian, Q. (2026). Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy. Advanced Science, 13(61). https://doi.org/10.1002/advs.77020
Vancouver
Zeng H, Zheng L, Tao R, Zheng S, Zhong Y, Niu Y, et al. Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy. Advanced Science. 2026;13(61). doi:10.1002/advs.77020
BibTeX
@article{Zeng2026,
author = {Zeng, Hongxiang and Zheng, Lei and Tao, Rongkun and Zheng, Sirui and Zhong, Yanke and Niu, Yongxia and Zhang, Peng and Ma, Xiang and Yang, Chen and Zhang, Min and Duan, Fuyu and Yang, Jing and Wei, Xuan and Zhou, Xiang and Yang, Zhenbiao and Sun, Zhaoxi and Lian, Qizhou},
title = {Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {61},
doi = {10.1002/advs.77020}
}
EUVIMED